Literature DB >> 7105386

Razoxane penetration into the cerebrospinal fluid of rats.

N Greig, F Xiao-Chang, K Hellmann.   

Abstract

Razoxane (100 mg/kg) was administered to rats as a single IP dose. Plasma and CSF samples were obtained at intervals varying from 15 min to 24 h after dosing, and the razoxane was assayed by a new and simple high performance liquid chromatography (HPLC) technique. Razoxane was absorbed quickly from the peritoneal cavity; it reached a peak concentration within 0.5 h and decayed with a half-life of 1.6 h. Only 10% of the plasma razoxane available entered the CSF, reaching a peak concentration by 2h, which was maintained for a further 4 h, and finally decaying to reach 10% of its peak value by 8 h.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7105386     DOI: 10.1007/BF00255492

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  5 in total

1.  Pharmacokinetics of ICRF-187 in the cerebrospinal fluid of subhuman primates.

Authors:  D D von Hoff; N Soares; P Gormley; D G Poplack
Journal:  Cancer Treat Rep       Date:  1980 Apr-May

2.  Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability.

Authors:  V A Levin
Journal:  J Med Chem       Date:  1980-06       Impact factor: 7.446

3.  Clinical trials with bis-dioxopiperazine propane (ICRF 159; NSC 129, 943) in acute leukaemias.

Authors:  P Krepler; J Pawlowsky
Journal:  Osterr Z Onkol       Date:  1975

4.  Limited activity of ICRF-159 in advanced acute leukemia.

Authors:  M T Bakowski; H G Prentice; T A Lister; J S Malpas; T J McElwain; R L Powles
Journal:  Cancer Treat Rep       Date:  1979-01

5.  Preliminary clinical assessment of I.C.R.F. 159 in acute leukaemia and lymphosarcoma.

Authors:  K Hellmann; K A Newton; D N Whitmore; I W Hanham; J V Bond
Journal:  Br Med J       Date:  1969-03-29
  5 in total
  3 in total

1.  Enhanced cerebrovascular permeability by Metrazol: significance for brain metastases.

Authors:  N Greig; K Hellmann
Journal:  Clin Exp Metastasis       Date:  1983 Jan-Mar       Impact factor: 5.150

2.  Metrazol enhances brain penetration and therapeutic efficacy of some anticancer agents: implications for brain metastases.

Authors:  N Greig; D Newell; K Hellmann
Journal:  Clin Exp Metastasis       Date:  1984 Jan-Mar       Impact factor: 5.150

3.  Absorption, distribution and excretion of ¹⁴C-probimane in mice bearing lewis lung carcinoma.

Authors:  Da-Yong Lu; Rui-Ting Chen; Ting-Ren Lu; Hong-Ying Wu; Rong-Xin Qu; Jin-Yu Che; Bin Xu
Journal:  Sci Pharm       Date:  2010-06-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.